Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity

BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is now the term used for hepatic steatosis in patients who are overweight or obese, have type 2 diabetes mellitus (T2DM), or evidence of metabolic dysregulation. The prevalence of MAFLD among morbidly obese subjects is 65–93%....

Descripción completa

Detalles Bibliográficos
Autores principales: Barranco-Fragoso, Beatriz, Pal, Shreya C., Díaz-Orozco, Luis E., Dorantes-Heredia, Rita, Qi, Xingshun, Méndez-Sánchez, Nahum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373829/
https://www.ncbi.nlm.nih.gov/pubmed/35934868
http://dx.doi.org/10.12659/MSM.937528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373829/
https://www.ncbi.nlm.nih.gov/pubmed/35934868
http://dx.doi.org/10.12659/MSM.937528

Ejemplares similares